LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis.
Catherine LeyhNiklas HeuckeClemens SchottenMatthias BuechterLars P BechmannMarc WichertAlexander DechêneKen HerrmannDominik HeiderSvenja SydorPeter LemmerJohannes M LudwigJosef PospiechJens Matthias TheysohnRobert DammChristine MarchMaciej PowerskiMaciej PechMustafa ÖzcürümezJochen WeigtVerena KeitelChristian M LangeHartmut H-J SchmidtPeter LemmerJan BestGuido GerkenPaul P MankaPublished in: Cancers (2022)
can be used as an additional tool to identify patients at high risk of post-interventional hepatic failure.
Keyphrases